492 related articles for article (PubMed ID: 11896992)
21. Scars and keloids.
Murray JC
Dermatol Clin; 1993 Oct; 11(4):697-708. PubMed ID: 8222353
[TBL] [Abstract][Full Text] [Related]
22. Keloids and hypertrophic scars: review and treatment strategies.
Urioste SS; Arndt KA; Dover JS
Semin Cutan Med Surg; 1999 Jun; 18(2):159-71. PubMed ID: 10385284
[TBL] [Abstract][Full Text] [Related]
23. Review of Silicone Gel Sheeting and Silicone Gel for the Prevention of Hypertrophic Scars and Keloids.
Hsu KC; Luan CW; Tsai YW
Wounds; 2017 May; 29(5):154-158. PubMed ID: 28570253
[TBL] [Abstract][Full Text] [Related]
24. Variations in gap junctional intercellular communication and connexin expression in fibroblasts derived from keloid and hypertrophic scars.
Lu F; Gao J; Ogawa R; Hyakusoku H
Plast Reconstr Surg; 2007 Mar; 119(3):844-51. PubMed ID: 17312486
[TBL] [Abstract][Full Text] [Related]
25. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
[TBL] [Abstract][Full Text] [Related]
26. Fibroproliferative scars.
Rahban SR; Garner WL
Clin Plast Surg; 2003 Jan; 30(1):77-89. PubMed ID: 12636218
[TBL] [Abstract][Full Text] [Related]
27. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
28. The role of nitric oxide in the formation of keloid and hypertrophic lesions.
Cobbold CA
Med Hypotheses; 2001 Oct; 57(4):497-502. PubMed ID: 11601878
[TBL] [Abstract][Full Text] [Related]
29. Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser: a novel efficient minimally-invasive technique.
Li K; Nicoli F; Cui C; Xi WJ; Al-Mousawi A; Zhang Z; Balzani A; Neill L; Sorge R; Tong Y; Zhang Y
Sci Rep; 2020 Dec; 10(1):21694. PubMed ID: 33303965
[TBL] [Abstract][Full Text] [Related]
30. Hypertrophic scars and keloids.
Haverstock BD
Clin Podiatr Med Surg; 2001 Jan; 18(1):147-59. PubMed ID: 11344975
[TBL] [Abstract][Full Text] [Related]
31. [Experimental study of actin and myosin in the scar tissue].
Zhang Q; Qian YL; Cui L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
[TBL] [Abstract][Full Text] [Related]
32. Fas-mediated apoptotic signal transduction in keloid and hypertrophic scar.
Lu F; Gao J; Ogawa R; Hyakusoku H; Ou C
Plast Reconstr Surg; 2007 May; 119(6):1714-1721. PubMed ID: 17440345
[TBL] [Abstract][Full Text] [Related]
33. Activated caspase expression and apoptosis increase in keloids: cytochrome c release and caspase-9 activation during the apoptosis of keloid fibroblast lines.
Akasaka Y; Ito K; Fujita K; Komiyama K; Ono I; Ishikawa Y; Akishima Y; Sato H; Ishii T
Wound Repair Regen; 2005; 13(4):373-82. PubMed ID: 16008726
[TBL] [Abstract][Full Text] [Related]
34. Clinical management of skin scarring.
Bayat A; McGrouther DA
Skinmed; 2005; 4(3):165-73. PubMed ID: 15891253
[TBL] [Abstract][Full Text] [Related]
35. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H
J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
[TBL] [Abstract][Full Text] [Related]
36. [Comparative study of collagen in hypertrophic and keloid cicatrix].
Podobed OV; Prozorovskiĭ NN; Kozlov EA; Tsvetkova TA; Vozdvizhenskiĭ SI; Del'vig AA
Vopr Med Khim; 1996; 42(3):240-5. PubMed ID: 9139458
[TBL] [Abstract][Full Text] [Related]
37. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
38. Study of microvascular structure in keloid and hypertrophic scars: density of microvessels and the efficacy of three-dimensional vascular imaging.
Kurokawa N; Ueda K; Tsuji M
J Plast Surg Hand Surg; 2010 Dec; 44(6):272-7. PubMed ID: 21446804
[TBL] [Abstract][Full Text] [Related]
39. [Hypertrophic scars and keloids: which therapeutic options today?].
Gailloud-Matthieu MC; Raffoul W; Egloff DV
Rev Med Suisse Romande; 1999 Sep; 119(9):721-8. PubMed ID: 10528514
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
